Strategic Participation of PMV Pharmaceuticals in Investor Conferences
PMV Pharmaceuticals Engages in Important Investor Conferences
PMV Pharmaceuticals, Inc. (Nasdaq: PMVP), a leader in precision oncology, is actively participating in several upcoming investor conferences. This strategic engagement aims to showcase their groundbreaking work in developing small molecule therapies targeting p53, a protein crucial in many cancers. CEO David H. Mack, Ph.D., and Chief Development Officer Deepika Jalota, Pharm. D., will represent the company at these events, highlighting key insights into their ongoing projects.
Event Details and Presentation Schedule
Their first appearance will be at the TD Cowen 6th Annual Oncology Innovation Summit. This will take place on Tuesday, May 27, 2025, at 11:30 AM EDT. The summit provides a platform for industry leaders to share insights related to oncology innovation, making it an excellent opportunity for PMV Pharmaceuticals to highlight their pioneering therapies.
Next, they will participate in the Jefferies Global Healthcare Conference on Thursday, June 5, 2025, at 3:45 PM EDT. These conferences allow PMV Pharma to connect with investors, analysts, and potential partners while discussing the crucial advancements in their product pipeline.
Live Webcasts for Enhanced Accessibility
For those interested in following the presentations, PMV Pharmaceuticals will provide a live audio webcast of each event, ensuring that stakeholders can access the information conveniently. Attendees can catch the live discussions online, and those who miss the presentations will have the opportunity to view archived replays for 90 days afterward.
About PMV Pharmaceuticals
Founded to address the pressing needs in oncology, PMV Pharmaceuticals focuses on innovative, tumor-agnostic therapies aimed at p53 mutations, which appear in around half of all cancer cases. The company’s co-founder, Dr. Arnold Levine, was pivotal in the discovery of the p53 protein in 1979, paving the way for the company's vision of harnessing this knowledge for therapeutic benefits.
PMV Pharmaceuticals leverages over forty years of research in p53 biology, combining deep scientific understanding with a strong focus on pharmaceutical development. Based in Princeton, New Jersey, the company continues to advance its commitment to delivering novel cancer treatments.
Investor and Media Contacts
For further information regarding investor relations, interested stakeholders can contact Tim Smith, Senior Vice President, Head of Corporate Development and Investor Relations. He can be reached via email at [email protected].
For media inquiries, Kathy Vincent from Greig Communications is the point of contact. She can be reached at [email protected].
Frequently Asked Questions
What is PMV Pharmaceuticals known for?
PMV Pharmaceuticals specializes in precision oncology, focusing on therapies targeting p53 mutations found in many cancers.
Who will represent PMV Pharma at the conferences?
David H. Mack, Ph.D., and Deepika Jalota, Pharm. D., will represent the company.
Where can I access the live webcasts?
The live webcasts of the presentations can be accessed through PMV Pharmaceuticals' official event page. Details will be provided during the conferences.
How long is the archived presentation available?
The archived presentation will be available for 90 days following the live event.
How can I contact PMV Pharmaceuticals for more information?
For investor-related queries, contact Tim Smith at [email protected], and for media inquiries, reach out to Kathy Vincent at [email protected].
About The Author
Contact Thomas Cooper privately here. Or send an email with ATTN: Thomas Cooper as the subject to [email protected].
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.